Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ZNF589 is a KRAB-zinc finger transcriptional repressor that plays critical roles in hematopoietic stem cell biology and cancer. It contains human-specific evolutionary changes and functions as a regulator of cell viability, apoptosis, and differentiation. The protein is downregulated in breast cancer through promoter hypermethylation and serves as a potential tumor suppressor and prognostic biomarker.
Transcriptional repression by binding DNA and operating through RNA polymerase II-specific mechanisms, mediated by its KRAB domain which interacts with TRIM28 and recruits histone deacetylase complexes, histone methylases, and heterochromatin proteins.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 589 (ZNF589).